scholarly journals Distribution of Highly Prevalent Musculoskeletal Disorders and Their Association With Diabetes Complications in a Population of 140 Individuals With Type 1 Diabetes: A Retrospective Study in a French Diabetes Center

2020 ◽  
Vol 38 (2) ◽  
pp. 181-187
Author(s):  
Sylvie Picard ◽  
Dimitar Vasilevski ◽  
Guy Fagherazzi
Keyword(s):  
Type 1 Diabetes ◽  
Retrospective Study ◽  
Musculoskeletal Disorders ◽  
Diabetes Complications ◽  
Diabetes Center

1514-P: Suboptimal Glycemic Control and High Prevalence of Diabetes Complications in Adults with Type 1 Diabetes (T1D) in the SAGE Study

Diabetes ◽  
2020 ◽  
Vol 69 (Supplement 1) ◽  
pp. 1514-P ◽  
Author(s):  
ERIC RENARD ◽  
ZSOLT BOSNYAK ◽  
FELIPE LAUAND ◽  
PAOLO POZZILLI ◽  
HIROSHI IKEGAMI ◽  
...  
Keyword(s):  
Type 1 Diabetes ◽  
Glycemic Control ◽  
Diabetes Complications ◽  
High Prevalence

scholarly journals Insulin doses requirements in patients with type 1 diabetes using glargine U300 or degludec in routine clinical practice

2021 ◽  
pp. jim-2020-001633
Author(s):  
Florentino Carral San Laureano ◽  
Mariana Tomé Fernández-Ladreda ◽  
Ana Isabel Jiménez Millán ◽  
Concepción García Calzado ◽  
María del Carmen Ayala Ortega
Keyword(s):  
Type 1 Diabetes ◽  
Clinical Practice ◽  
Retrospective Study ◽  
Real World ◽  
Glycosylated Hemoglobin ◽  
Routine Clinical Practice ◽  
Insulin Analogs ◽  
Total P ◽  
Real Clinical Practice

There are not many real-world studies evaluating daily insulin doses requirements (DIDR) in patients with type 1 diabetes (T1D) using second-generation basal insulin analogs, and such comparison is necessary. The aim of this study was to compare DIDR in individuals with T1D using glargine 300 UI/mL (IGlar-300) or degludec (IDeg) in real clinical practice. An observational, retrospective study was designed in 412 patients with T1D (males: 52%; median age 37.0±13.4 years, diabetes duration: 18.7±12.3 years) using IDeg and IGla-300 ≥6 months to compare DIDR between groups. Patients using IGla-300 (n=187) were more frequently males (59% vs 45.8%; p=0.004) and had lower glycosylated hemoglobin (HbA1c) (7.6±1.2 vs 8.1%±1.5%; p<0.001) than patients using IDeg (n=225). Total (0.77±0.36 unit/kg/day), basal (0.43±0.20 unit/kg/day) and prandial (0.33±0.23 unit/kg/day) DIDR were similar in IGla-300 and IDeg groups. Patients with HbA1c ≤7% (n=113) used significantly lower basal (p=0.045) and total (p=0.024) DIDR, but not prandial insulin (p=0.241), than patients with HbA1c between 7.1% and 8% and >8%. Patients using IGla-300 and IDeg used similar basal, prandial and total DIDR regardless of metabolic control subgroup. No difference in basal, prandial and total DIDR was observed between patients with T1D using IGla-300 or IDeg during at least 6 months in routine clinical practice.

Bariatric surgery in the treatment of patients with obesity and type 1 diabetes: A retrospective study of clinical data

2021 ◽  
Author(s):  
Nagi Mohammed ◽  
Adam Buckley ◽  
Mohgah Elsheikh ◽  
Matthew Allum ◽  
Sara Suliman ◽  
...  
Keyword(s):  
Bariatric Surgery ◽  
Type 1 Diabetes ◽  
Retrospective Study ◽  
Clinical Data

scholarly journals Family and household structure are associated with acute type 1 diabetes complications: results of cross‐sectional analyses

2020 ◽  
Vol 37 (12) ◽  
pp. 2075-2080 ◽  
Author(s):  
C. Baechle ◽  
A. Stahl‐Pehe ◽  
K. Castillo ◽  
V. Gontscharuk ◽  
R. W. Holl ◽  
...  
Keyword(s):  
Type 1 Diabetes ◽  
Diabetes Complications ◽  
Household Structure ◽  
Acute Type ◽  
Cross Sectional ◽  
Family And Household

scholarly journals Hepatic Steatosis Index Is Associated with Type 1 Diabetes Complications

2019 ◽  
Vol Volume 12 ◽  
pp. 2405-2410 ◽  
Author(s):  
Cesare Tripolino ◽  
Concetta Irace ◽  
Antonio Cutruzzolà ◽  
Martina Parise ◽  
Milena Barone ◽  
...  
Keyword(s):  
Type 1 Diabetes ◽  
Hepatic Steatosis ◽  
Diabetes Complications ◽  
Hepatic Steatosis Index
Sign in / Sign up

Export Citation Format

Share Document